Guardant Health (GH) Common Equity: 2017-2025
Historic Common Equity for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to -$354.5 million.
- Guardant Health's Common Equity fell 489.84% to -$354.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$354.5 million, marking a year-over-year decrease of 489.84%. This contributed to the annual value of -$139.6 million for FY2024, which is 188.00% down from last year.
- Latest data reveals that Guardant Health reported Common Equity of -$354.5 million as of Q3 2025, which was down 16.04% from -$305.5 million recorded in Q2 2025.
- In the past 5 years, Guardant Health's Common Equity ranged from a high of $847.0 million in Q1 2021 and a low of -$354.5 million during Q3 2025.
- Its 3-year average for Common Equity is -$37.1 million, with a median of -$44.6 million in 2023.
- As far as peak fluctuations go, Guardant Health's Common Equity surged by 253.27% in 2024, and later tumbled by 18,838.31% in 2025.
- Over the past 5 years, Guardant Health's Common Equity (Quarterly) stood at $645.0 million in 2021, then plummeted by 90.67% to $60.2 million in 2022, then skyrocketed by 163.68% to $158.7 million in 2023, then slumped by 188.00% to -$139.6 million in 2024, then slumped by 489.84% to -$354.5 million in 2025.
- Its Common Equity stands at -$354.5 million for Q3 2025, versus -$305.5 million for Q2 2025 and -$250.8 million for Q1 2025.